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ABSTRACT 
Hb Malay was first described in 1989 following an investigation of anaemia in a 22-year-old 
Malay gentleman who was homozygous for this b chain variant. This Hb variant is caused by 
AAC à AGC mutation at codon 19 of the b globin gene resulting in the substitution of serine 
for asparagine [1]. The mutation creates cryptic RNA splice site in exon 1 of the b-globin 
gene leading to an abnormal RNA processing. Thus, this mutation not only produces variant 
haemoglobin but also a mild b+ thalassemia phenotype [2]. A retrospective analysis was 
carried out at the Clinical Haematology Laboratory, Hospital Ampang, Selangor, Malaysia 
from 2012 to 2015. A total of 12 cases of confirmed heterozygous, homozygous or compound 
heterozygous of Hb Malay were collected. The diagnostic workups in this centre included 
complete blood count (CBC), blood smear, haemoglobin analysis and molecular study. Table 
1 shows the haematological characteristics of Hb Malay and its combination with other 
thalassaemia/ haemoglobinopathies. Table 2 shows the clinical features and transfusion 
requirements of various presentation of Hb Malay. The definitive diagnosis of Hb Malay can 
only be made by molecular analysis. Both reverse phase high performance liquid 
chromatography (HPLC) for haemoglobin variant and capillary zone electrophoresis (CZE) 
cannot differentiate between Hb A and Hb Malay as it is co-migrated. Previously, it was 
reported that there was an increased production of Hb F between 12-32% in cases of 
homozygous Hb Malay and compound heterozygous Hb E/Malay [3]. In our case, the Hb F 
levels in homozygous Hb Malay were 47.4% and 30%, respectively (Case 1 and 2). Patients 
with homozygous Hb Malay were non-transfusion dependent with average haemoglobin of 7 
to 8g/dL, whereas in Hb Malay trait the haemoglobin level was normal. The Hb E/ Malay 
patients were also asymptomatic, although the average haemoglobin was lower (10g/dL) 
compared to the classical Hb E trait (12.4g/dL) [5]. Hb F level in Hb E/ Malay was reported 
to be above 12% [3], in one of our cases, the Hb F was only 3.3% (Case 4). Molecular 
analysis showed this patient was also homozygous for 158 Gγ Xmn polymorphism, as well as 
-α3.7 deletion. This was rather an interesting finding as this polymorphism was associated 
with higher level of Hb F [4]. Similarly, the presence of alpha thalassaemia was reported to 
reduce the Hb E percentage to less than 25%, but in this case the Hb E was 52.6% [5]. 
Compound heterozygous of Hb Malay/ Beta thalassaemia resulted in thalassaemia intermedia 
with variable phenotypes depending on the type of mutations. The other 2 combinations of 
Hb Malay with Hb S and HPFH also presented as thalassaemia intermedia. These findings 
were in keeping with the phenotype of Hb Malay resembling b+ thalassaemia. 
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